
==== Front
J Korean Assoc Oral Maxillofac Surg
J Korean Assoc Oral Maxillofac Surg
Journal of the Korean Association of Oral and Maxillofacial Surgeons
2234-7550
2234-5930
The Korean Association of Oral and Maxillofacial Surgeons

39211966
10.5125/jkaoms.2024.50.4.177
jkaoms-50-4-177
Review Article
The role of endoplasmic reticulum stress in the pathogenesis of oral diseases
https://orcid.org/0000-0002-4283-499X
Mustakim Kezia Rachellea
https://orcid.org/0000-0001-7055-9924
Eo Mi Young
https://orcid.org/0000-0002-6916-0489
Kim Soung Min
Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea
Soung Min Kim, Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea, TEL: +82-2-6256-3132, E-mail: smin5@snu.ac.kr, ORCID: https://orcid.org/0000-0002-6916-0489
31 8 2024
31 8 2024
31 8 2024
50 4 177188
20 8 2023
13 10 2023
Copyright © 2024 The Korean Association of Oral and Maxillofacial Surgeons. All rights reserved.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The endoplasmic reticulum (ER) is crucial for protein synthesis, transport, and folding, as well as calcium storage, lipid and steroid synthesis, and carbohydrate metabolism. Endoplasmic reticulum stress (ERS) occurs when misfolded or unfolded proteins accumulate in the ER lumen due to increased protein secretion or impaired folding. While the role of ERS in disease pathogenesis has been widely studied, most research has focused on extraoral diseases, leaving the role of ERS in intraoral diseases unclear. This review examines the role of ERS in oral diseases and oral fibrosis pathogenesis. A systematic search of literature through July 2023 was conducted in the MEDLINE database (via PubMed) using specific terms related to ERS, oral diseases, and fibrosis. The findings were summarized in both table and narrative form. Emerging evidence indicates that ERS significantly contributes to the pathogenesis of oral diseases and fibrosis. ERS-induced dysregulation of protein folding and the unfolded protein response can lead to cellular dysfunction and inflammation in oral tissues. Understanding the relationship between ERS and oral disease pathogenesis could offer new therapeutic targets for managing oral health and fibrosis-related complications.

Endoplasmic reticulum stress
Fibrosis
Oral pathology
Pathogenesis-related proteins
Unfolded protein response
Funding No funding to declare.
==== Body
pmcI. Background

The endoplasmic reticulum (ER) is a cellular organelle that plays an important role in proteogenic synthesis and conveyance, protein conformational maturation, calcium sequestration, biosynthesis of lipids and steroids, and metabolic processes related to carbohydrates1. Due to its multiple functions, the ER is closely connected to the preservation of cellular balance and the delicate equilibrium between well-being and disease2. Endoplasmic reticulum stress (ERS) is characterized by an overload of misfolded or unfolded proteins in the ER lumen due to increased protein secretion or impaired ER protein folding.

The unfolded protein response (UPR) in eukaryotic cells is a complex signaling system that modulates gene transcription, translation of mRNA, and post-translational alterations of proteins. The UPR mitigates the buildup of unfolded or misfolded proteins and restores proteostasis by ensuring accurate protein folding and preserving the proper ER function3. When activated, UPR signaling pathways can trigger intercellular inflammatory signals. In chronic conditions this may lead to the development of many diseases and is associated with the progression of degenerative and fibrotic ailments in several organs4,5. The role of ERS in disease pathogenesis has been described previously. However, most such studies focused only on extraoral diseases, and the role of ERS in intraoral diseases is unclear. This review examines the role of ERS in oral diseases and oral fibrosis pathogenesis.

II. Methods

This review was structured based on Arksey and O’Malley6 methodological framework for a scoping review.

1. Focal question

Does ERS contribute to oral diseases and oral fibrosis pathogenesis?

2. Identification of relevant studies

A systematic search of relevant literature published through July 2023 was conducted in the MEDLINE database (via PubMed) using the following controlled-vocabulary terms combined with Boolean operators: (endoplasmic reticulum stress) OR (unfolded protein response) AND (disease), (endoplasmic reticulum stress) OR (unfolded protein response) AND (fibrosis). To investigate the role of ERS in the pathogenesis of disease affecting the oral maxillofacial region, the following MeSH, Emtree, DeCS/MeSH, and other free terms combined with Boolean operators were used: (endoplasmic reticulum stress) OR (unfolded protein response) AND (oral disease).

3. Selection

The articles were selected based on titles and abstracts. Inclusion criteria included in vitro, in vivo, and clinical studies on ERS in oral disease. Literature reviews, irrelevant studies, non-English articles, and articles published in non-peer review journals were excluded. A manual search was also performed using the reference list of selected articles.

III. Results

The flow of the search is shown in Fig. 1. The search resulted in 396 articles. After excluding 386 duplicate and irrelevant articles, 10 articles were analyzed by reading the titles, abstracts, and full manuscripts. Two articles were added after reading the reference lists of the selected articles, resulting in 12 articles (Table 1) categorized into the following topics: gingival and periodontal diseases (7 articles), salivary gland disease and malignancy (2 articles), oral squamous cell carcinoma (OSCC) (3 articles) and our summarized data regarding contributory proteins in ERS, including UPR, apoptosis, necroptosis, autophagy, angiogenesis, inflammatory signaling, and epithelial-mesenchymal transition.

1. Gingival and periodontal disease

During periodontal and gingival inflammation, various stressors such as microbial pathogens and inflammatory mediators can induce ERS and UPR. In a study by Kim et al.7,8 of thapsigargin (TG)-induced ERS in human gingival fibroblast cells, p38 mitogen-activated protein kinase was shown to play a significant role in cell death and autophagy, with increased expression of beclin-1 and microtubule-associated protein 1 light chain 3 II (LC3II) as well as the formation of autophagic vesicles. Furthermore, selenoprotein S (SEPS) and heat shock protein 60 were highly expressed in the periodontitis, and the presence of Porphyromonas gingivalis independently aggravated alveolar bone resorption and significantly correlated with increased glucose-regulated protein (GRP) 78, X-box binding protein 1 spliced form (XBP1s), triiodothyronine receptor auxiliary protein, and cathepsin K expression9,10. Elevated expression of activating transcription factor (ATF) 6β was evident during tunicamycin-induced ERS in periodontal mice, with increased expression of the receptor activator of nuclear factor-kappa B (NF-κB) ligand (RANKL) in periodontal ligament cells. These biomarkers were associated with increased resorption of periodontal bone, and treatment using microRNA (miR)-1260b and ATF6β small interfering RNA (siRNA) with polyethylenimine nanoparticles significantly inhibited periodontal bone resorption11. In drug-induced gingival hyperplasia, cyclosporine can increase the expression of CCAAT/enhancer-binding protein homologous protein (CHOP), GRP78, XBP1s, vascular endothelial growth factor (VEGF), connective tissue growth factor (CTGF), B-cell lymphoma 2 (Bcl-2), and cyclophilin D while decreasing cytochrome c, and shift gingival metabolism equilibrium toward an anabolic state, resulting in overgrowth and fibrosis12,13. In addition, treatment using 4-phenylbutyric acid, melatonin, and simvastatin were shown to downregulate the expression of ERS markers, mitochondrial apoptosis markers, and autophagy8,12.

2. Salivary gland disease and malignancy

In a study by Katsiougiannis et al.14, TG-induced ERS led to autophagy, as evidenced by the expression of LC3II and apoptosis in human salivary gland cells. In quiescent cells, Ro/SSA and La/SSB autoantigens are localized predominantly to the cytoplasm. However, in apoptotic cells, these autoantigens underwent relocalization and were found on the cell membrane and blebs in the apoptotic membrane. Kaira et al.15 reported the involvement of ERS in adenoid cystic carcinoma (ACC) through the identification of positive GRP78/BiP expression in ACC specimens. This is indicative of an unfavorable prognostic biomarker, demonstrating a significant association with increased cellular proliferation and angiogenesis.

3. Oral squamous cell carcinoma

In OSCC cells, heightened protein synthesis and changes in the tumor microenvironment (TME) can trigger ERS. These changes initiate an UPR, promote cell survival and facilitate tumor growth. However, persistent or unresolved ERS can also contribute to the advancement of OSCC by stimulating tumor-cell invasion, migration, and resistance to therapeutic interventions16.

Sufficient ERS can induce signal transducers and activators of transcription 3 (STAT3), NF-κB signaling, and interleukin (IL)-6. Under tunicamycin-induced ERS, normal oral keratinocytes showed significant upregulation of genes for STAT3 and leukemia inhibitory factor receptor (LIF-R), IL-6 receptor (IL-6R), and IL-18R1. Conversely, in OSCC tissue, significantly more cyclic AMP-responsive element-binding protein 3-like 3 (CREB3L3), STAT3, IL-6R, and sterol regulatory element-binding protein (SREBP) 1 were expressed17,18. The activation of STAT3 and NF-κB were activated in tunicamycin-induced ERS in OSCC cells through the upregulation of IL-5, IL-22, and LIF-R17. LIF-R is expressed by cancer-associated fibroblasts (CAFs) and plays an important role in the activation of STAT3 in the TME of OSCCs, promoting the invasion of cancer cells19. In addition, ERS can change gene-expression profiles from regulators of lipid metabolism to controllers of apoptosis18.

Cancer-associated fibroblasts are a heterogeneous population of activated fibroblasts originating from mesenchymal cell lines within the TME. Due to the absence of distinctive biomarkers, determining the source of CAFs remains challenging. The prevailing view suggests that regular fibroblasts arise from primitive mesenchymal cells, and CAFs emerge from activated fibroblasts in nearby tissues, bone marrow-derived mesenchymal precursor cells, and endothelial and epithelial cells, some of which are stimulated by cytokines such as TGFβ20,21.

Several inflammatory mediators may stimulate activation of CAFs. For example, IL-1 triggers CAF activation via the NF-κB pathway, and IL-6 primarily acts on signal transducers and STAT. Positive feedback loops and crosstalk involving Janus kinase (JAK)-STAT signaling, changes in the contractile cytoskeleton, and modifications in histone acetylation further contribute to CAF activation. Physical alterations in the extracellular matrix (ECM) can also serve as stimuli for CAF activation22.

The reverse Warburg effect is considered a hallmark of CAF regulation. Metabolite transfer from CAFs to cancer cells is important element of cancer cell growth and survival. In addition to CAF regulation, prolonged hypoxia can cause glycolysis-related genes in fibroblasts to undergo hypomethylation, indicating that metabolic interactions with epigenetic processes promote the buildup of pro-glycolytic CAFs23. Because hypoxia is associated with a UPR, a strong relationship likely exists between the ERS and CAF, and future studies are warranted.

Due to the complexity of OSCC pathogenesis, numerous studies have excluded the potential contribution of proteins and genes. Dentin sialophosphoprotein (DSPP), which facilitates dentin and bone matrix mineralization, is reportedly involved in cancer pathogenesis. DSPP is present in non-mineralizing metabolically active ductal epithelial cells of various glands, such as salivary glands, nephrons, and eccrine sweat glands, and helps repair pericellular matrix and ECM proteins damaged by free radicals generated during intense metabolic activity24. In OSCC cells transiently transfected and not exposed to puromycin, silencing of DSPP resulted in significant downregulation of GRP78, sarco/ER Ca+2-ATPase 2b (SERCA2b), protein kinase R (PKR)-like ER kinase (PERK), inositol-requiring enzyme type 1 (IRE1), ATF6, and matrix metalloproteinase (MMP)-20. Silencing DSPP can lead to reduced cell viability and migration accompanied by increased apoptosis in OSCC cells. In addition, DSPP knockdown resulted in decreased levels of proliferating cell nuclear antigen, an indicator of cell proliferation, and Bcl-2, an anti-apoptotic protein. Conversely, levels of Bax, a pro-apoptotic protein, and cytochrome c were elevated in DSPP-silenced OSCC cells25.

4. Contributory proteins in endoplasmic reticulum stress

1) Unfolded protein response

• IRE1: inositol requiring enzyme 1

• PERK: protein kinase RNA-activated (PKR-like) ER kinase

• ATF6: activating transcription factor 6

• GRP78: glucose-regulated protein 78

• XBP1: X-box-binding protein 1

• PDIA5: protein Disulphide Isomerase 5

• PDIA6: protein Disulphide Isomerase 6

2) Apoptosis

• CHOP/GADD153: CCAAT-enhancer-binding protein homologous protein/Growth arrest-and DNA damage-inducible gene 153

• PUMA: p53-up regulated modulator of apoptosis

• Noxa: pro-apoptotic member of the Bcl-2 protein family

• BIM: Bcl-2 interacting mediator of cell death

3) Necroptosis

• RIPK1: receptor-interacting protein kinase 1

• RIPK3: receptor-interacting protein kinase 3

• MLKL: mixed-lineage kinase domain-like protein

4) Autophagy

• TRAF2: TNF receptor-associated factor 2

• JNK: c-Jun N-terminal kinases

• ASK1: apoptosis signal-regulating kinase 1

• LC3: microtubule-associated protein 1 light chain 3

5) Angiogenesis

• VEGF: vascular endothelial growth factor

• IL-8: interleukin 8

• MMP2: matrix metalloproteinase 2

• MMP9: matrix metalloproteinase 9

• ANG-2: angiopoietin 2

• HIF-1: hypoxia-inducible factor

• FGF2: fibroblast growth factor 2

6) Inflammatory signaling

• NF-kB: nuclear factor kappa light-chain-enhanced activated B-cells

• AP-1: activator protein 1

• NLRP3 inflammasome: nucleotide-binding domain (NOD)-, leucine-rich repeat (LRR)-, and pyrin domain-containing protein 3

• IL1β: interleukin 1 beta

• IL18: interleukin 18

7) Epithelial-mesenchymal transition

• TGFβ: transforming growth factor beta

• αSMA: α-smooth muscle actin

• E-cadherin: epithelial cadherin

• N-cadherin: neural cadherin

• Vimentin

• Fibronectin

• miR-150: microRNA 150

IV. Discussion

1. Structure of the oral mucosa

The oral mucosa consists of a stratifying squamous epithelium that is largely covered by a keratinized epithelium over a dense connective tissue or lamina propria rich in type I collagen. This structural arrangement serves as a protective barrier against external microorganisms, pathogens, and mechanical stress, particularly in the gingiva and hard palate26. For flexibility in deglutition, mastication, and speech, the floor of the mouth and buccal mucosa are composed of a nonkeratinizing epithelium. In addition, the dorsum of the tongue is covered by a specialized mosaic of keratinized and nonkeratinized epithelium that attaches tightly to the tongue muscle27.

Keratins are the main structural proteins in the keratinizing stratified epithelial cytoskeleton. Basal cells, which form the actively dividing layer of the epithelium, connect to the lamina densa of the lamina basalis via hemidesmosomes. The spinous cell layers play a crucial role in facilitating cell-cell connections through numerous desmosomes and gap junctions. The stratum granulosum contains membrane-coating granules, keratohyalin granules, and abundant tonofibrils, leading to an abrupt transition to the stratum corneum. The flattened cornified squames form a relatively thick protective layer. To maintain their function, the stratified epithelia of the oral mucosa use tight cell-cell adhesion in viable cells combined with intercellular tight and adherens junctions that connect to the actin cytoskeleton28,29.

During the healing process in response to oral mucosa injury following hemostasis, the formation of fibrin-rich granulation tissue initiates the inflammatory phase. Next, the wound-healing process enters a proliferative phase characterized by the migration of keratinocytes and fibroblasts to the wound bed. Fibroblasts actively secrete ECM components, which contribute to remodeling of granulation tissue, and keratinocytes play a crucial role in re-establishing the protective barrier function of the tissue. Unlike skin, oral mucosa heals better and typically results in rapid and scarless healing. Distinct variations in wound healing occur within the oral environment contingent on the specific location. Wounds in the non-keratinized mucosa may lead to scarring, and wounds in the tongue or gingiva and hard palate heal uneventfully without scarring. These dissimilarities can be ascribed to differences in the characteristics of resident fibroblasts26,30.

Nikoloudaki et al.26 suggested periostin may influence cell behavior during the proliferative phase of healing by identifying intracellular proximal localization between periostin and fibronectin in the ER of fibroblast cells. As a response to injury, the periostin enhances secretion of fibronectin from the ER into the ECM, leading to fibrosis and scarring. Periostin has also been identified in several pathologic conditions, including fibrous dysplasia31, odontogenic tumors of mixed epithelial/mesenchymal origin32, and OSCC33. This strengthens the hypothesis that intracellular ERS, such as in oral fibroblasts, can influence the secretion and expression of several proteins into the ECM, resulting in the development of oral disease and fibrosis.

2. UPR and ERS

During ERS, three transmembrane proteins in the ER membrane (IRE1, PERK, and ATF6) are activated to initiate a UPR34. Typically, the ER resident chaperone HSP A5 keeps the three ERS sensors in an inactive state. This chaperone is also referred to as GRP78 and binds to immunoglobulin protein (BiP). However, an accumulation of misfolded proteins in the ER lumen leads to engagement of BiP, releasing the three sensors to initiate the UPR2.

1) IRE1 pathway

IRE1 possesses both serine/threonine kinase and endoribonuclease (RNase) domains in its cytoplasmic region. Comparisons between yeast IRE1 and its mammalian homologs, IRE1α and IRE1β, have demonstrated a significant degree of conservation. IRE1α is expressed in various cells and tissues, and IRE1β expression is mainly limited to the epithelial cells of the gastrointestinal tract35. On encountering ERS, the release of GRP78/BiP from IRE1α leads to its preferential binding to unfolded or misfolded proteins, resulting in dimerization and autophosphorylation. This process activates IRE1α, transforming it into an active endoribonuclease36. The activated IRE1 initiates unconventional splicing of the XBP1 mRNA, which is later translated into the potent transcription factor XBP1s3. Specifically, XBP1s contains a basic leucine zipper (bZIP) domain in the C terminus and serves as a transcription factor for UPR-related genes, including those for ER chaperones, ER-associated degradation (ERAD) components, and lipid synthesis enzymes35. XBP1s regulates the expression of various genes involved in ER protein folding and ERAD, enhancing folding capacity and clearing misfolded proteins, including molecular chaperones BiP and transcription factors such as CHOP36,37. IRE1α degrades mRNA as well as microRNAs (miRs), which regulate cellular functions, including proliferation, differentiation, and apoptosis, and abnormal miR expression can be found in various human diseases, including fibrosis. In a study by Heindryckx et al.37, miR-150 exhibited an anti-fibrotic function that suppressed the expression of c-Myb and TGFβ-induced αSMA, and activated IRE1α-degraded miR-150, resulting in the formation of myofibroblasts.

2) PERK pathway

An immediate adaptive response to ERS is initiated by PERK. Similar to IRE1α activation, PERK is activated when GRP78/BiP is released from its binding site in the ER lumen36. PERK phosphorylates eukaryotic initiation factor 2α (eIF2α), a crucial component of protein translation machinery. Phosphorylated eIF2α has a dual effect on protein synthesis: it reduces the entire protein-synthesis process and selectively enhances the translation of ATF4 and other specific mRNAs. ATF4 triggers the transcription of genes associated with the equilibrium of cellular oxidation-reduction processes, amino acid metabolism, protein synthesis, apoptosis, and autophagy, giving cells the ability to adapt to the stress or undergo apoptosis if the stress becomes overwhelming3. ATF4 can bind to the C/EBP-ATF site in the CHOP/GADD153 promoter region. ATF4 and CHOP function as transcription factors that directly stimulate genes associated with protein synthesis and the UPR. However, upregulation of protein synthesis by ATF4 and CHOP can deplete ATP, generating oxidative stress and ultimately cell death2. PDI is an essential enzyme found in the ER lumen, where it ensures nascent (newly synthesized) proteins acquire their functional three-dimensional structures as they fold. PDI functions as a redox regulator, helping the ER maintain the appropriate redox environment for disulfide bond formation and other redox-dependent processes. The role of PDI in protein folding and redox homeostasis is closely associated with activation of the PERK pathway during ERS38. In a study by Eletto et al.39, PDIA6 was shown to regulate the deactivation of the UPR sensor IRE1α by binding directly to its luminal domain through the formation of a disulfide bond. Because the luminal domains of IRE1 and PERK are homologous, interaction between PDIA6 and PERK was also observed.

3) ATF6 pathway

Under ERS, ATF6 migrates from the ER to the Golgi apparatus, where it is proteolytically cleaved by site-1 and site-2 proteases, resulting in an active bZIP transcription factor known as ATF6p503. Under stress conditions, PDIA5 facilitates the reorganization of disulfide bonds in ATF6α, promoting the translocation of ATF6α from the ER to the cell nucleus40. The active ATF6 enters the nucleus and upregulates genes for chaperones and other ER-resident proteins, including BiP, GRP94, calreticulin, and ERAD system components, further supporting protein folding and clearance5.

3. ERS and inflammatory signaling

NF-κB plays a pivotal role in inflammation response and is typically confined within the cytoplasm by the inhibitor of NF-κB (IκB). During inflammation, various stimuli, including pro-inflammatory cytokines, activate IκB kinases, leading to phosphorylation and degradation of IκB41. Under ERS, a UPR induces the degradation of IκB through the IRE1α pathway and tumor necrosis factor receptor-associated factor 2 (TRAF2). In addition, activation of JNK by IRE1α induces the expression of activator protein (AP-1)42. The primary function of AP-1 is to bind to specific DNA sequences in the promoter regions of target genes and regulate their transcription, particularly during inflammation and apoptosis. ERS can also modify the phenotype of macrophages by activating the NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inflammasomes5. When activated, NLRP3 can induce activation of caspase-1, which then processes pro-inflammatory cytokines, including IL-1β and IL-18, into their active forms43. In addition, ERS through IRE1α is required for the maturation and differentiation of plasma and dendritic cells as well as polarization of Th17 cells5.

4. ERS and apoptosis, necroptosis, and autophagy

Apoptosis involves initiation, signaling, and execution. Key players in the apoptotic pathway include members of the Bcl-2 proteins, which are divided into pro-apoptotic (e.g., Bax, Bak) and anti-apoptotic (e.g., Bcl-2, Bcl-XL) proteins44. The BH-3-only members of the Bcl-2 family, including p53-upregulated modulator of apoptosis (PUMA), NOXA, and Bcl-2 interacting mediator of cell death BIM, are significant in ERS-induced apoptosis45. Pro-apoptotic proteins promote the release of cytochrome c from the mitochondria into the cytoplasm, where it forms a complex with apoptotic protease-activating factor 1 (Apaf-1) and procaspase-9, ultimately producing apoptosomes46. This complex activates caspase-9, which in turn activates downstream effector caspases (e.g., caspase-3 and caspase-7), leading to the cleavage of various cellular substrates and ultimately, cell death47. In addition to direct ER-mitochondrial interactions, CHOP/GADD153 is involved in the regulation of apoptosis as the apoptosis inducer by activating BIM and PUMA as well as repressing several anti-apoptotic members of the Bcl-2 family2.

Necroptosis is a programmed form of necrosis that represents an alternative cell-death pathway when apoptotic pathways are inhibited or unavailable. Necroptosis is characterized by the rapid and uncontrolled breakdown of cellular membranes, leading to the release of cellular contents and inflammation. The molecular machinery involved in necroptosis includes RIPKs, and RIPK1 and RIPK3 in particular. These kinases form a complex, the necrosome, when apoptosis is blocked, resulting in phosphorylation of MLKL48. Phosphorylated MLKL translocates to the plasma membrane and disrupts its integrity, resulting in cell swelling, membrane rupture, and the release of intracellular contents49. In a study using a mouse fibroblast cell line, TNFR1 mediated ERS-induced necroptosis by activating caspase. The MLKL served as an effector of ERS and repression of RIPK1 shifted the ERS-induced necroptosis to apoptosis50.

In addition to ERAD, lysosome-mediated protein degradation by autophagy is another protein degradation pathway during ERS42. Bernales et al.51 reported that ERS induces abundant cell-accumulated autophagosome-like structures enclosed by two membranes and containing densely packed, closely arranged membrane cisternae. Autophagy is induced by ERS by at least two UPR pathways, PERK-elF2α and IRE1α. The IRE1α pathway involves TRAF2, ASK1, and JNK. The PERK-elF2α pathway induces autophagy through ATF4-driven transcriptional regulation by inducing vesicle elongation. Ca2+ release from the ER lumen through the inositol 1,4,5-trisphosphate receptor (IP3R) can activate calcium/calmodulin-dependent protein kinase and relieves mammalian target of rapamycin inhibition on the Unc-51-like kinase 1 complex2,52.

5. ERS and angiogenesis

The interplay between ERS and angiogenesis is complex and involves various signaling pathways. Hypoxia-inducible factor 1 plays a key role in cellular responses to changes in oxygen levels, specifically hypoxia, and plays a role in angiogenesis. Under ERS conditions, the activation of PERK and IRE1 branches of the UPR can lead to increased HIF-1α stabilization and transcriptional activity. Subsequently, HIF-1α promotes the expression of pro-angiogenic factors, including VEGF, erythropoietin (EPO), angiopoietin 2 (ANG-2), and MMPs, to stimulate angiogenesis53. In a study by Ghosh et al.54, VEGF expression during ERS was promoted by the activation of ATF4, XBP1s, and cleaved ATF6, independent from HIF-1. Under ERS, IL-8 is also upregulated through the PERK pathway by ATF455. As a pro-angiogenic cytokine, IL-8 activity further induces the expression of MMP-2 and MMP-9, which are critical players in angiogenesis, by mediating ECM remodeling and promoting endothelial cell migration and proliferation while decreasing endothelial cell apoptosis56. In addition to VEGF and IL-8, FGF 2 and angiogenin, potent pro-angiogenic factors that contribute to endothelial cell proliferation and tube formation, are upregulated57.

6. ERS and EMT

During epithelial-mesenchymal transition, epithelial cells lose their cell-cell adhesion characteristics and acquire a migratory and invasive phenotype characteristic of mesenchymal cells. This process is regulated by various complex signaling pathways and transcription factors. In addition to the loss of adherens junctions, EMT also includes downregulation of cytokeratin and E-cadherin and increases of fibronectin, N-cadherin, and vimentin58. UPR activation can alter the function of fibroblasts by promoting TGFβ-mediated myofibroblast differentiation5; one such mechanism is through degradation of miR-150 by activated IRE1α that consecutively regulates αSMA expression37. The IRE1-XBP1 pathway can also negatively regulate E-cadherin and upregulate N-cadherin2. On PERK activation, the epithelial cells are subjected to EMT, and the process of invasion and metastasis depend on eIF2α phosphorylation59. Additional pathways have also have been suggested to induce EMT, such as autophagy and the activation of c-SRC kinase in tubular epithelial cells as well as the compensatory activation of nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 (NRF-2/HO-1) antioxidative stress response pathway in colorectal adenocarcinoma cell lines60,61.

V. Conclusion

Emerging evidence suggests that ERS plays a crucial part in the pathogenesis of oral diseases and fibrosis. ERS-induced dysregulation of protein folding and the UPR can lead to cellular dysfunction and inflammation in oral tissues. In addition, ERS-related alterations in autophagy, apoptotic pathways, and activation of CAFs may further exacerbate tissue damage, impair wound healing, and facilitate favorable TME for further tumor growth and metastasis. Understanding the intricate interplay between ERS and oral disease pathogenesis will provide new insights potential therapeutic targets for managing oral health and fibrosis-related complications.

Acknowledgments

This study was supported by the National Research Foundation of Korea through the Ministry of Education (2022R1I1A1A01070644) and by the Ministry of Science and ICT (2022R1F1A1069624).

Fig. 1 Identification of relevant literature.

Table 1 Studies on ERS in the oral and maxillofacial regions

No.	Disease	Possible mechanism of ERS	Possible implications of ERS in the disease pathomechanism	Intervention	
Gingival and periodontal diseases	
1.	Periodontal and gingival inflammation	TG-induced ERS induced by increasing several ERS-inducible, UPR-related proteins including GRP78, GRP94, C/EBP homologous protein, phospho-eIF-2α, eIF-2α, phospho-JNK1 (p46), phospho-JNK2/3 (p54), JNK1, IRE1α, PERK, sXBP-1, beclin-1, LC3II, and autophagic vacuoles8	p38 mitogen-activated protein kinase participates in ERS-associated cell death and autophagy of gingival fibroblasts7	4PBA decreased the ERS markers and inhibited the autophagy induced by ERS8	
2.	Periodontitis	High expression levels of XBP1, ATF4, SEPS1, CHOP, and HSP 609
Porphyromonas gingivalis significantly increases GRP78, XBP1s, TRAP, and cathepsin K and insignificantly CHOP levels10
Induction of ERS in periodontal mouse model was accompanied by enhanced ATF6β expression
Within PDL cells, the ER stimulant tunicamycin augmented expression of RANKL11	An inflammatory reaction could exert a significant impact on the UPR9
ERS triggered by P. gingivalis contributes to alveolar bone loss in mice through mechanisms that are separate from the involvement of inflammatory cytokines10
Interaction between PDL cells and osteoclasts plays a role in Regulation of ERS-induced periodontal bone resorption11	Not applicable
4PBA suppresses the UPR-related genes (GRP78, XBP1s, CHOP, IRE1α) and osteoclastic differentiation (TRAP, and cathepsin K)10
The application of miR-1260b and ATF6β siRNA via PEI-NPs locally resulted in substantial reduction of bone resorption in the periodontal area
miR-1260b downregulated ATF6β leading to inhibition of RANKL. Additionally, the conditioned media from PDL cells activated by miR-1260b/ATF6β-axis exhibited the ability to hinder osteoclast formation in CD14+ monocytes derived from human peripheral blood11	
3.	Drug-induced gingival overgrowth	Cyclosporine increases ERS markers (CHOP, GRP7813, XBPs), matrix protein markers (VEGF and CTGF), and mitochondrial apoptosis markers (Bcl-2 and cyclophilin D), and decreases cytochrome c12	Cyclosporine, although inducing ERS, shifts the balance of gingival metabolism toward an anabolic state leading to overgrowth12, 13	4PBA, melatonin, and simvastatin decreased ERS and matrix protein markers where PBA further decreased mitochondrial apoptosis markers12	
Salivary gland disorder and malignancy	
4.	Sjögren syndrome	GRP78/BiP expression was observed in acinar and ductal epithelial cells within salivary glands of both patients and sicca controls
Treatment with TG led to autophagy activation, as evidenced by the heightened LC3II protein levels; furthermore, TG treatment prompted an increase in XBP-1 protein levels, indicative of UPR, accompanied by a decrease in GRP78/BiP levels. Notably, TG treatment also induced apoptosis in human salivary glands
Ro/SSA and La/SSB autoantigens were primarily situated within the cytoplasm in quiescent cells, yet in apoptotic cells, they underwent relocalization to the cell membrane and exhibited formation of membrane blebs14	ERS-induced apoptosis in human salivary gland cells leads to cell surface and apoptotic bleb relocalization of Ro/SSA and La/SSB autoantigens14	Not applicable	
5.	ACC	Elevated GRP78/BiP expression showed a substantial correlation with both PERK activation and cell proliferation, as indicated by the Ki-67 labeling index15	The pivotal involvement of GRP78/BiP and PERK is evident in driving the aggressiveness and advancement of ACC tumor growth15	Not applicable	
OSCC	
6.	OSCC	Normal oral keratinocytes response to tunicamycin-induced ERS involving significant upregulation of STAT3 and LIF-R proteins as well as IL6R and IL18R1 genes, both of which are STAT3 and NFκB signaling activators
ERS induces STAT3 and NFκB signaling and upregulates IL-6; both STAT3 and IL-6R proteins were expressed to significantly higher extent in OSCC tissue. OSCC cells responded to tunicamycin-induced ERS caused by upregulation of IL-5 and IL-2217
Both OSCC cases, with or without tunicamycin-induced ERS, exhibited noteworthy upregulation of SREBP1 and CREB3L3
In OSCC, a notably elevated level of SREBP1 transcriptional activation was observed; on ERS induction, apoptotic genes (DDIT3, HTRA4, and HSPA1L) displayed significantly upregulated in OSCC18
In OSCC cells that were transiently transfected and maintained without puromycin, the suppression of DSPP led to a significant reduction in the mRNA expression of key genes, including GRP78, SERCA2b, PERK, IRE1, ATF6, and MMP-20
DSPP silencing also led to diminished cell viability and migration, accompanied by heightened apoptotic events. Moreover, DSPP knockdown resulted in decreased levels of PCNA and Bcl-2 levels, while promoting increased levels of Bax and cytochrome c proteins within OSCC cells25	Tunicamycin-induced ERS upregulated tumor-promoting cytokines IL5 and IL22 in OSCC. IL5 and IL22 further activated STAT3 and/or NFκB. In addition, LIF-R plays an important role in STAT3 activation in OSCC17
In response to ERS, OSCC cells manifest a more concentrated UPR in comparison to normal oral keratinocytes, which includes modulation of lipid metabolism regulators
Tunicamycin-induced ERS brought about distinctive variations in the regulation of UPR genes, shifting from those governing lipid metabolism to those influencing apoptosis18
DSPP may participate in ERS processes within OSCC
The suppression of DSPP within OSCC cells resulted in notable changes in the abundant of key ERS-related proteins, subsequently leading to the disruption of the UPR mechanism25	Not applicable	
(ERS: endoplasmic reticulum stress, TG: thapsigargin, UPR: unfolded protein response, GRP: glucoseregulated protein, C/EBP: CCAAT/enhancerbinding protein, eIF: eukaryotic initiation factor, JNK: c-Jun N-terminal kinase, IRE1: inositol-requiring enzyme type 1, PERK: protein kinase R [PKR]-like endoplasmic reticulum kinase, XBP: X-box binding protein, LC3: microtubule-associated protein 1A/1B-light chain 3, 4PBA: 4-phenylbutric acid, ATF: activating transcription factor, SEPS: selenoprotein S, CHOP: C/EBP homologous protein, HSP: heat shock protein, TRAP: triiodothyronine receptor auxiliary protein, PDL: periodontal ligament, ER: endoplasmic reticulum, RANKL: receptor activator of NF- κB ligand, miR: microRNA, siRNA: small interfering RNA, PEI-NPs: polyethylenimine nanoparticles, VEGF: vascular endothelial growth factor, CTGF: connective tissue growth factor, Bcl-2: B-cell lymphoma 2, XBPs: X-box binding protein spliced, ACC: adenoid cystic carcinoma, OSCC: oral squamous cell carcinoma, STAT: signal transducer and activator of transcription, LIF-R: leukemia inhibitory factor receptor, IL: interleukin, IL [number] R: interleukin [number] receptor, NF-κB: nuclear factor-kappa B, SREBP1: sterol regulatory element-binding protein 1, CREB3L3: cyclic AMP responsive element-binding protein 3-like 3, DDIT: DNA damage inducible transcript, HTRA: high-temperature requirement A, DSPP: dentin sialophosphoprotein, SERCA: sarco/endoplasmic reticulum Ca2+-ATPase, MMP: matrix metalloproteinase, PCNA: proliferating cell nuclear antigen)

Authors’ Contributions

K.R.M. wrote the manuscript. M.Y.E. helped prepare and edit the manuscript. S.M.K. designed the study and coordinated and carefully reviewed and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Conflict of Interest

No potential conflict of interest relevant to this article was reported.
==== Refs
References

1 Schwarz DS Blower MD 2016 The endoplasmic reticulum: structure, function and response to cellular signaling Cell Mol Life Sci 73 79 94 https://doi.org/10.1007/s00018-015-2052-6 10.1007/s00018-015-2052-6 26433683
2 Almanza A Carlesso A Chintha C Creedican S Doultsinos D Leuzzi B 2019 Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications FEBS J 286 241 78 https://doi.org/10.1111/febs.14608 10.1111/febs.14608 30027602
3 Hetz C Zhang K Kaufman RJ 2020 Mechanisms, regulation and functions of the unfolded protein response Nat Rev Mol Cell Biol 21 421 38 https://doi.org/10.1038/s41580-020-0250-z 10.1038/s41580-020-0250-z 32457508
4 Marciniak SJ 2019 Endoplasmic reticulum stress: a key player in human disease FEBS J 286 228 31 https://doi.org/10.1111/febs.14740 10.1111/febs.14740 30677245
5 Kropski JA Blackwell TS 2018 Endoplasmic reticulum stress in the pathogenesis of fibrotic disease J Clin Invest 128 64 73 https://doi.org/10.1172/JCI93560 10.1172/JCI93560 29293089
6 Arksey H O'Malley L 2005 Scoping studies: towards a methodological framework Int J Soc Res Methodol 8 19 32 https://doi.org/10.1080/1364557032000119616 10.1080/1364557032000119616
7 Kim DS Kim JH Lee GH Kim HT Lim JM Chae SW 2010 p38 Mitogen-activated protein kinase is involved in endoplasmic reticulum stress-induced cell death and autophagy in human gingival fibroblasts Biol Pharm Bull 33 545 9 https://doi.org/10.1248/bpb.33.545 10.1248/bpb.33.545 20410583
8 Kim DS Li B Rhew KY Oh HW Lim HD Lee W 2012 The regulatory mechanism of 4-phenylbutyric acid against ER stress-induced autophagy in human gingival fibroblasts Arch Pharm Res 35 1269 78 https://doi.org/10.1007/s12272-012-0718-2 10.1007/s12272-012-0718-2 22864750
9 Domon H Takahashi N Honda T Nakajima T Tabeta K Abiko Y 2009 Up-regulation of the endoplasmic reticulum stress-response in periodontal disease Clin Chim Acta 401 134 40 https://doi.org/10.1016/j.cca.2008.12.007 10.1016/j.cca.2008.12.007 19109937
10 Yamada H Nakajima T Domon H Honda T Yamazaki K 2015 Endoplasmic reticulum stress response and bone loss in experimental periodontitis in mice J Periodontal Res 50 500 8 https://doi.org/10.1111/jre.12232 10.1111/jre.12232 25223277
11 Hayashi C Fukuda T Kawakami K Toyoda M Nakao Y Watanabe Y 2022 miR-1260b inhibits periodontal bone loss by targeting ATF6β mediated regulation of ER stress Front Cell Dev Biol 10 1061216 https://doi.org/10.3389/fcell.2022.1061216 10.3389/fcell.2022.1061216 36531939
12 Ranga Rao S Subbarayan R Ajitkumar S Murugan Girija D 2018 4PBA strongly attenuates endoplasmic reticulum stress, fibrosis, and mitochondrial apoptosis markers in cyclosporine treated human gingival fibroblasts J Cell Physiol 233 60 6 https://doi.org/10.1002/jcp.25836 10.1002/jcp.25836 28158898
13 Rao SR Ajitkumar S Subbarayan R Girija DM 2018 Cyclosporine-A induces endoplasmic reticulum stress in human gingival fibroblasts - an in vitro study J Oral Biol Craniofac Res 8 165 7 https://doi.org/10.1016/j.jobcr.2016.11.002 10.1016/j.jobcr.2016.11.002 30191101
14 Katsiougiannis S Tenta R Skopouli FN 2015 Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells Clin Exp Immunol 181 244 52 https://doi.org/10.1111/cei.12638 10.1111/cei.12638 25845745
15 Kaira K Toyoda M Shimizu A Shino M Sakakura K Takayasu Y 2016 Expression of ER stress markers (GRP78/BiP and PERK) in adenoid cystic carcinoma Acta Otolaryngol 136 1 7 https://doi.org/10.3109/00016489.2015.1083120 10.3109/00016489.2015.1083120 26366837
16 Giampietri C Petrungaro S Conti S Facchiano A Filippini A Ziparo E 2015 Cancer microenvironment and endoplasmic reticulum stress response Mediators Inflamm 2015 417281 https://doi.org/10.1155/2015/417281 10.1155/2015/417281 26491226
17 Yakin M Seo B Rich A 2019 Tunicamycin-induced endoplasmic reticulum stress up-regulates tumour-promoting cytokines in oral squamous cell carcinoma Cytokine 120 130 43 https://doi.org/10.1016/j.cyto.2019.04.013 10.1016/j.cyto.2019.04.013 31071674
18 Seo B Coates DE Lewis J Seymour GJ Rich AM 2022 Unfolded protein response is involved in the metabolic and apoptotic regulation of oral squamous cell carcinoma Pathology 54 874 81 https://doi.org/10.1016/j.pathol.2022.04.003 10.1016/j.pathol.2022.04.003 35791990
19 Ohata Y Tsuchiya M Hirai H Yamaguchi S Akashi T Sakamoto K 2018 Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma PLoS One 13 e0191865 https://doi.org/10.1371/journal.pone.0191865 10.1371/journal.pone.0191865 29444110
20 Ping Q Yan R Cheng X Wang W Zhong Y Hou Z 2021 Cancer-associated fibroblasts: overview, progress, challenges, and directions Cancer Gene Ther 28 984 99 https://doi.org/10.1038/s41417-021-00318-4 10.1038/s41417-021-00318-4 33712707
21 Bu L Baba H Yoshida N Miyake K Yasuda T Uchihara T 2019 Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment Oncogene 38 4887 901 https://doi.org/10.1038/s41388-019-0765-y 10.1038/s41388-019-0765-y 30816343
22 Sahai E Astsaturov I Cukierman E DeNardo DG Egeblad M Evans RM 2020 A framework for advancing our understanding of cancer-associated fibroblasts Nat Rev Cancer 20 174 86 https://doi.org/10.1038/s41568-019-0238-1 10.1038/s41568-019-0238-1 31980749
23 Yang D Liu J Qian H Zhuang Q 2023 Cancer-associated fibroblasts: from basic science to anticancer therapy Exp Mol Med 55 1322 32 https://doi.org/10.1038/s12276-023-01013-0 10.1038/s12276-023-01013-0 37394578
24 Joshi R Tawfik A Edeh N McCloud V Looney S Lewis J 2010 Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2 PLoS One 5 e13974 https://doi.org/10.1371/journal.pone.0013974 10.1371/journal.pone.0013974 21103065
25 Gkouveris I Nikitakis NG Aseervatham J Ogbureke KUE 2018 The tumorigenic role of DSPP and its potential regulation of the unfolded protein response and ER stress in oral cancer cells Int J Oncol 53 1743 51 https://doi.org/10.3892/ijo.2018.4484 10.3892/ijo.2018.4484 30015841
26 Nikoloudaki G Creber K Hamilton DW 2020 Wound healing and fibrosis: a contrasting role for periostin in skin and the oral mucosa Am J Physiol Cell Physiol 318 C1065 77 https://doi.org/10.1152/ajpcell.00035.2020 10.1152/ajpcell.00035.2020 32267719
27 Squier CA Kremer MJ 2001 Biology of oral mucosa and esophagus J Natl Cancer Inst Monogr 2001 7 15 https://doi.org/10.1093/oxfordjournals.jncimonographs.a003443 10.1093/oxfordjournals.jncimonographs.a003443 11694559
28 Groeger SE Meyle J 2015 Epithelial barrier and oral bacterial infection Periodontol 2000 69 46 67 https://doi.org/10.1111/prd.12094 10.1111/prd.12094 26252401
29 Groeger S Meyle J 2019 Oral mucosal epithelial cells Front Immunol 10 208 https://doi.org/10.3389/fimmu.2019.00208 10.3389/fimmu.2019.00208 30837987
30 Kabakov L Nemcovsky CE Plasmanik-Chor M Meir H Bar DZ Weinberg E 2021 Fibroblasts from the oral masticatory and lining mucosa have different gene expression profiles and proliferation rates J Clin Periodontol 48 1393 401 https://doi.org/10.1111/jcpe.13532 10.1111/jcpe.13532 34409631
31 Kashima TG Nishiyama T Shimazu K Shimazaki M Kii I Grigoriadis AE 2009 Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions Hum Pathol 40 226 37 https://doi.org/10.1016/j.humpath.2008.07.008 10.1016/j.humpath.2008.07.008 18799196
32 Chau E Daley T Darling MR Hamilton D 2013 The expression and immunohistochemical localization of periostin in odontogenic tumors of mixed epithelial/mesenchymal origin Oral Surg Oral Med Oral Pathol Oral Radiol 116 214 20 https://doi.org/10.1016/j.oooo.2013.05.008 10.1016/j.oooo.2013.05.008 23849375
33 Siriwardena BS Kudo Y Ogawa I Kitagawa M Kitajima S Hatano H 2006 Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer Br J Cancer 95 1396 403 https://doi.org/10.1038/sj.bjc.6603431 10.1038/sj.bjc.6603431 17060937
34 Wiseman RL Mesgarzadeh JS Hendershot LM 2022 Reshaping endoplasmic reticulum quality control through the unfolded protein response Mol Cell 82 1477 91 https://doi.org/10.1016/j.molcel.2022.03.025 10.1016/j.molcel.2022.03.025 35452616
35 So JS 2018 Roles of endoplasmic reticulum stress in immune responses Mol Cells 41 705 16 https://doi.org/10.14348/molcells.2018.0241 30078231
36 Park K Lee SE Shin KO Uchida Y 2019 Insights into the role of endoplasmic reticulum stress in skin function and associated diseases FEBS J 286 413 25 https://doi.org/10.1111/febs.14739 10.1111/febs.14739 30586218
37 Heindryckx F Binet F Ponticos M Rombouts K Lau J Kreuger J 2016 Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing EMBO Mol Med 8 729 44 https://doi.org/10.15252/emmm.201505925 10.15252/emmm.201505925 27226027
38 Kranz P Neumann F Wolf A Classen F Pompsch M Ocklenburg T 2017 PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR) Cell Death Dis 8 e2986 https://doi.org/10.1038/cddis.2017.369 10.1038/cddis.2017.369 28796255
39 Eletto D Eletto D Dersh D Gidalevitz T Argon Y 2014 Protein disulfide isomerase A6 controls the decay of IRE1α signaling via disulfide-dependent association Mol Cell 53 562 76 https://doi.org/10.1016/j.molcel.2014.01.004 10.1016/j.molcel.2014.01.004 24508390
40 Higa A Taouji S Lhomond S Jensen D Fernandez-Zapico ME Simpson JC 2014 Endoplasmic reticulum stress-activated transcription factor ATF6α requires the disulfide isomerase PDIA5 to modulate chemoresistance Mol Cell Biol 34 1839 49 https://doi.org/10.1128/MCB.01484-13 10.1128/MCB.01484-13 24636989
41 Oeckinghaus A Ghosh S 2009 The NF-kappaB family of transcription factors and its regulation Cold Spring Harb Perspect Biol 1 a000034 https://doi.org/10.1101/cshperspect.a000034 10.1101/cshperspect.a000034 20066092
42 Schröder M 2008 Endoplasmic reticulum stress responses Cell Mol Life Sci 65 862 94 https://doi.org/10.1007/s00018-007-7383-5 10.1007/s00018-007-7383-5 18038217
43 Kelley N Jeltema D Duan Y He Y 2019 The NLRP3 inflammasome: an overview of mechanisms of activation and regulation Int J Mol Sci 20 3328 https://doi.org/10.3390/ijms20133328 10.3390/ijms20133328 31284572
44 Papaliagkas V Anogianaki A Anogianakis G Ilonidis G 2007 The proteins and the mechanisms of apoptosis: a mini-review of the fundamentals Hippokratia 11 108 13 19582203
45 Kim H Tu HC Ren D Takeuchi O Jeffers JR Zambetti GP 2009 Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis Mol Cell 36 487 99 https://doi.org/10.1016/j.molcel.2009.09.030 10.1016/j.molcel.2009.09.030 19917256
46 Garrido C Galluzzi L Brunet M Puig PE Didelot C Kroemer G 2006 Mechanisms of cytochrome c release from mitochondria Cell Death Differ 13 1423 33 https://doi.org/10.1038/sj.cdd.4401950 10.1038/sj.cdd.4401950 16676004
47 Elmore S 2007 Apoptosis: a review of programmed cell death Toxicol Pathol 35 495 516 https://doi.org/10.1080/01926230701320337 10.1080/01926230701320337 17562483
48 Wegner KW Saleh D Degterev A 2017 Complex pathologic roles of RIPK1 and RIPK3: moving beyond necroptosis Trends Pharmacol Sci 38 202 25 https://doi.org/10.1016/j.tips.2016.12.005 10.1016/j.tips.2016.12.005 28126382
49 Seo J Nam YW Kim S Oh DB Song J 2021 Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators Exp Mol Med 53 1007 17 https://doi.org/10.1038/s12276-021-00634-7 10.1038/s12276-021-00634-7 34075202
50 Saveljeva S Mc Laughlin SL Vandenabeele P Samali A Bertrand MJ 2015 Endoplasmic reticulum stress induces ligand-independent TNFR1-mediated necroptosis in L929 cells Cell Death Dis 6 e1587 https://doi.org/10.1038/cddis.2014.548 10.1038/cddis.2014.548 25569104
51 Bernales S McDonald KL Walter P 2006 Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response PLoS Biol 4 e423 https://doi.org/10.1371/journal.pbio.0040423 10.1371/journal.pbio.0040423 17132049
52 Sano R Reed JC 2013 ER stress-induced cell death mechanisms Biochim Biophys Acta 1833 3460 70 https://doi.org/10.1016/j.bbamcr.2013.06.028 10.1016/j.bbamcr.2013.06.028 23850759
53 Binet F Sapieha P 2015 ER Stress and angiogenesis Cell Metab 22 560 75 https://doi.org/10.1016/j.cmet.2015.07.010 10.1016/j.cmet.2015.07.010 26278049
54 Ghosh R Lipson KL Sargent KE Mercurio AM Hunt JS Ron D 2010 Transcriptional regulation of VEGF-A by the unfolded protein response pathway PLoS One 5 e9575 https://doi.org/10.1371/journal.pone.0009575 10.1371/journal.pone.0009575 20221394
55 Gargalovic PS Imura M Zhang B Gharavi NM Clark MJ Pagnon J 2006 Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids Proc Natl Acad Sci U S A 103 12741 6 https://doi.org/10.1073/pnas.0605457103 10.1073/pnas.0605457103 16912112
56 Li A Dubey S Varney ML Dave BJ Singh RK 2003 IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis J Immunol 170 3369 76 https://doi.org/10.4049/jimmunol.170.6.3369 10.4049/jimmunol.170.6.3369 12626597
57 Pereira ER Liao N Neale GA Hendershot LM 2010 Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response PLoS One 5 e12521 https://doi.org/10.1371/journal.pone.0012521 10.1371/journal.pone.0012521 20824063
58 Ribatti D Tamma R Annese T 2020 Epithelial-mesenchymal transition in cancer: a historical overview Transl Oncol 13 100773 https://doi.org/10.1016/j.tranon.2020.100773 10.1016/j.tranon.2020.100773 32334405
59 Feng YX Sokol ES Del Vecchio CA Sanduja S Claessen JH Proia TA 2014 Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stress Cancer Discov 4 702 15 https://doi.org/10.1158/2159-8290.CD-13-0945 10.1158/2159-8290.CD-13-0945 24705811
60 Moon SY Kim HS Nho KW Jang YJ Lee SK 2014 Endoplasmic reticulum stress induces epithelial-mesenchymal transition through autophagy via activation of c-Src kinase Nephron Exp Nephrol 126 127 40 https://doi.org/10.1159/000362457 10.1159/000362457 24863135
61 Chang YJ Chen WY Huang CY Liu HH Wei PL 2015 Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway Tumour Biol 36 1859 69 https://doi.org/10.1007/s13277-014-2788-x 10.1007/s13277-014-2788-x 25431258
